Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征

2020-01-20 欧洲心脏病学会 Eur Heart J Acute Cardiovasc Care. 2020 Jan 20:204

急诊胸痛患急性冠脉综合征

本文主要提供了欧洲心脏病学会(ESC)工作组关于胸痛的管理报告，主要目的是提供供急诊急诊胸痛患者诊断和危险分层的决策流程和诊断路径。

中文标题：

2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征

英文标题：

Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association.

发布机构：

欧洲心脏病学会

发布日期：

2020-01-20

简要介绍：

本文主要提供了欧洲心脏病学会(ESC)工作组关于胸痛的管理报告，主要目的是提供供急诊急诊胸痛患者诊断和危险分层的决策流程和诊断路径。

 

拓展指南：与胸痛相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征)] GetToolGuiderByIdResponse(projectId=1, id=0ba221c00185a684, title=2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征, enTitle=Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association., guiderFrom=Eur Heart J Acute Cardiovasc Care. 2020 Jan 20:204, authorId=null, author=, summary=本文主要提供了欧洲心脏病学会(ESC)工作组关于胸痛的管理报告，主要目的是提供供急诊急诊胸痛患者诊断和危险分层的决策流程和诊断路径。 , cover=, journalId=null, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Mon Jan 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>本文主要提供了欧洲心脏病学会(ESC)工作组关于胸痛的管理报告，主要目的是提供供急诊急诊胸痛患者诊断和危险分层的决策流程和诊断路径。 </P> <P> </P>拓展指南：<strong>与<font color=red>胸痛</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=30ae61c001832e76" title="胸痛基层诊疗指南（2019年）" target=_blank>胸痛基层诊疗指南（2019年）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=ac27d1c001e5817b" title="急性胸痛急诊诊疗专家共识" target=_blank>急性胸痛急诊诊疗专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1331a1c001a85250" title="2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性" target=_blank>2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1018e1c0012095b7" title="急性非创伤性胸痛生物标志物联合检测专家共识" target=_blank>急性非创伤性胸痛生物标志物联合检测专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=3e13f1c00110167f" title="2014 胸痛规范化评估与诊断中国专家共识" target=_blank>2014 胸痛规范化评估与诊断中国专家共识</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%83%B8%E7%97%9B" target=_blank>有关胸痛更多指南</a></ul>, tagList=[TagDto(tagId=99041, tagName=急诊胸痛患), TagDto(tagId=360, tagName=急性冠脉综合征)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=36888, appHits=280, showAppHits=15, pcHits=2842, showPcHits=35158, likes=60, shares=13, comments=9, approvalStatus=1, publishedTime=Sat Jan 25 22:26:39 CST 2020, publishedTimeString=2020-01-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 25 22:26:39 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:48:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征)])
2020 ESC-ACCA意见书：急诊胸痛患者诊断和危险分层——聚焦急性冠脉综合征
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=969600, encodeId=743696960081, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Sun May 30 09:14:19 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968657, encodeId=b27d96865e86, content=好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Wed May 26 15:23:13 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912877, encodeId=9f469128e750, content=很实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9E4DEC48EF53AC9A6B738A238FAE77A1/100, createdBy=3fba2264945, createdName=李维华, createdTime=Fri Jan 01 13:55:55 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904863, encodeId=1d41904863a9, content=点赞，梅斯医学上的资源真多！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 04 14:42:59 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884518, encodeId=623a884518aa, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=ms4000001950390745, createdTime=Fri Sep 11 11:29:16 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-05-30 1281668446

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=969600, encodeId=743696960081, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Sun May 30 09:14:19 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968657, encodeId=b27d96865e86, content=好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Wed May 26 15:23:13 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912877, encodeId=9f469128e750, content=很实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9E4DEC48EF53AC9A6B738A238FAE77A1/100, createdBy=3fba2264945, createdName=李维华, createdTime=Fri Jan 01 13:55:55 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904863, encodeId=1d41904863a9, content=点赞，梅斯医学上的资源真多！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 04 14:42:59 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884518, encodeId=623a884518aa, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=ms4000001950390745, createdTime=Fri Sep 11 11:29:16 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-05-26 zhangxiang

    好，学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=969600, encodeId=743696960081, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Sun May 30 09:14:19 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968657, encodeId=b27d96865e86, content=好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Wed May 26 15:23:13 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912877, encodeId=9f469128e750, content=很实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9E4DEC48EF53AC9A6B738A238FAE77A1/100, createdBy=3fba2264945, createdName=李维华, createdTime=Fri Jan 01 13:55:55 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904863, encodeId=1d41904863a9, content=点赞，梅斯医学上的资源真多！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 04 14:42:59 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884518, encodeId=623a884518aa, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=ms4000001950390745, createdTime=Fri Sep 11 11:29:16 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-01-01 李维华

    很实用！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=969600, encodeId=743696960081, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Sun May 30 09:14:19 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968657, encodeId=b27d96865e86, content=好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Wed May 26 15:23:13 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912877, encodeId=9f469128e750, content=很实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9E4DEC48EF53AC9A6B738A238FAE77A1/100, createdBy=3fba2264945, createdName=李维华, createdTime=Fri Jan 01 13:55:55 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904863, encodeId=1d41904863a9, content=点赞，梅斯医学上的资源真多！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 04 14:42:59 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884518, encodeId=623a884518aa, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=ms4000001950390745, createdTime=Fri Sep 11 11:29:16 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2020-12-04 taken110

    点赞，梅斯医学上的资源真多！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=969600, encodeId=743696960081, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Sun May 30 09:14:19 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968657, encodeId=b27d96865e86, content=好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Wed May 26 15:23:13 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912877, encodeId=9f469128e750, content=很实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9E4DEC48EF53AC9A6B738A238FAE77A1/100, createdBy=3fba2264945, createdName=李维华, createdTime=Fri Jan 01 13:55:55 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904863, encodeId=1d41904863a9, content=点赞，梅斯医学上的资源真多！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 04 14:42:59 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884518, encodeId=623a884518aa, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=ms4000001950390745, createdTime=Fri Sep 11 11:29:16 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2020-09-11 ms4000001950390745

    很好，很实用

    0

Baidu
map
Baidu
map
Baidu
map